Sébastien Halter
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Sébastien Halter has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- Alexandre Louvet
Service des maladies de l'appareil digestif, University Hospital of Lille, Lille, France; Unite INSERM INFINITE, Lille, France
1 shared publication - Antoine Monsel
CHU Pitié-Salpêtrière, AP-HP, Paris, France
1 shared publication - Audrey Coilly
Centre Hépato-Biliaire, hôpital Paul-Brousse AP-HP, Université Paris-Saclay, Inserm U1193, Paris, France
1 shared publication - Baptiste Giguet
Service des maladies du foie, hôpital Pontchaillou, CHU Rennes, Rennes Liver Failure Group RELIEF, Rennes, France
1 shared publication Cassandra Rayer
Univ Rennes, Ctr Hospitalier, Gastroenterol Dept, Rennes, France
1 shared publication- Constantine J. Karvellas
Department of Critical Care Medicine, University of Alberta, Edmonton, Canada
1 shared publication
Latest Publications
- Open Access
- 8 September 2026
- Published by Wolters Kluwer Health in Liver Transplantation
Evaluation of available scoring systems in liver transplantation for severe acute-on-chronic liver failure (ACLF)
The Transplantation for ACLF-3 Model (TAM) and Sundaram ACLF-LT-Mortality score (SALT-M) have been proposed to help select liver transplantation (LT) candidates with acute-on-chronic liver failure (ACLF) to optimize post-LT outcomes. We assessed the performance and clinical utility of these scores and their components on a large retrospective international multicenter study. All patients transplanted in the context of ACLF grade 3 (n=336) from 9 international cohorts (2008–2024) were included in the study. The primary endpoint was 1-year post-LT survival. Score discrimination, calibration, and clinical utility using decision-curve (net benefit) analysis were assessed. The 1-year post-LT survival rate was 75.3%. Both TAM (OR 1.91, p =0.0001) and SALT-M (OR 1.09, p 25 (46.9% vs. 78.7%). Respiratory failure (PaO 2 /FiO 2 ≤200) was associated with 1-year post-LT mortality, whereas other variables included in the original scores, diabetes, BMI, and leukocyte count, did not demonstrate significant prognostic value in this cohort. In this large multicenter study, TAM and SALT-M were associated with post-LT mortality but demonstrated limited discriminative accuracy. Candidate high-risk thresholds (TAM ≥3, SALT-M >25) may help identify a small subset of patients with markedly poor post-LT outcomes. However, given their modest performance, these scores should support, not replace, multidisciplinary decision-making, and their applicability should be evaluated in a prospective fashion.
- 8 September 2026
- Published by Wolters Kluwer Health in Liver Transplantation
Open AccessEvaluation of available scoring systems in liver transplantation for severe acute-on-chronic liver failure (ACLF)
The Transplantation for ACLF-3 Model (TAM) and Sundaram ACLF-LT-Mortality score (SALT-M) have been proposed to help select liver transplantation (LT) candidates with acute-on-chronic liver failure (ACLF) to optimize post-LT outcomes. We assessed the performance and clinical utility of these scores and their components on a large retrospective international multicenter study. All patients transplanted in the context of ACLF grade 3 (n=336) from 9 international cohorts (2008–2024) were included in the study. The primary endpoint was 1-year post-LT survival. Score discrimination, calibration, and clinical utility using decision-curve (net benefit) analysis were assessed. The 1-year post-LT survival rate was 75.3%. Both TAM (OR 1.91, p =0.0001) and SALT-M (OR 1.09, p 25 (46.9% vs. 78.7%). Respiratory failure (PaO 2 /FiO 2 ≤200) was associated with 1-year post-LT mortality, whereas other variables included in the original scores, diabetes, BMI, and leukocyte count, did not demonstrate significant prognostic value in this cohort. In this large multicenter study, TAM and SALT-M were associated with post-LT mortality but demonstrated limited discriminative accuracy. Candidate high-risk thresholds (TAM ≥3, SALT-M >25) may help identify a small subset of patients with markedly poor post-LT outcomes. However, given their modest performance, these scores should support, not replace, multidisciplinary decision-making, and their applicability should be evaluated in a prospective fashion.
- 18 February 2023
- Published by Elsevier in Gastroenterology
- Vol. 165 (2) , 347-349
A Woman With Recurrent Upper Gastrointestinal Bleeding
- 18 February 2023
- Published by Elsevier in Gastroenterology
- Vol. 165 (2) , 347-349
A Woman With Recurrent Upper Gastrointestinal Bleeding